Charlene Tow

623 total citations
4 papers, 507 citations indexed

About

Charlene Tow is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Charlene Tow has authored 4 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Oncology and 1 paper in Rheumatology. Recurrent topics in Charlene Tow's work include Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers) and Oral and gingival health research (1 paper). Charlene Tow is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers) and Oral and gingival health research (1 paper). Charlene Tow collaborates with scholars based in Singapore, France and Australia. Charlene Tow's co-authors include Alessandra Nardin, Jean‐Pierre Abastado, Caleb Huang, Valerie Chew, Han Chong Toh, Armelle Prévost‐Blondel, Jean-Pierre Abastado, Marie-Françoise Avril, Charles R. Mackay and Michelle Hong and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Journal of Hepatology.

In The Last Decade

Charlene Tow

4 papers receiving 500 citations

Peers

Charlene Tow
Comparison fields: 5 of 53
  • Immunology 340
  • Oncology 326
  • Molecular Biology 82
  • Cancer Research 73
  • Hepatology 72
Replace Angela D. Pardee with:
Angela D. Pardee United States
Pingping Hu China
Lorea Villanueva Spain
Hannah M. Schutz Netherlands
Yanan Gao China
Mordehay Klepfish Israel
Clément Barjon France
Nancy Díaz‐Valdés Spain
Eleonora Cremonesi Switzerland
Hui-Juan Qiu China
Angela D. Pardee United States View profile →
Citations per field, relative to Charlene Tow
Charlene Tow · 1×
Citations per year, relative to Charlene Tow
Charlene Tow · 1×

Countries citing papers authored by Charlene Tow

Since Specialization
Citations

This map shows the geographic impact of Charlene Tow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlene Tow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlene Tow more than expected).

Fields of papers citing papers by Charlene Tow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlene Tow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlene Tow. The network helps show where Charlene Tow may publish in the future.

Co-authorship network of co-authors of Charlene Tow

This figure shows the co-authorship network connecting the top 25 collaborators of Charlene Tow. A scholar is included among the top collaborators of Charlene Tow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlene Tow. Charlene Tow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
# Work Indexed citations
1 72
2 192
3 29
4 214

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026